Cargando…
A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics
Combination chemotherapy is crucial for successfully treating cancer. However, the enormous number of possible drug combinations means discovering safe and effective combinations remains a significant challenge. To improve this process, we conduct large-scale targeted CRISPR knockout screens in drug...
Autores principales: | Lee, Hyeong-Min, Wright, William C., Pan, Min, Low, Jonathan, Currier, Duane, Fang, Jie, Singh, Shivendra, Nance, Stephanie, Delahunty, Ian, Kim, Yuna, Chapple, Richard H., Zhang, Yinwen, Liu, Xueying, Steele, Jacob A., Qi, Jun, Pruett-Miller, Shondra M., Easton, John, Chen, Taosheng, Yang, Jun, Durbin, Adam D., Geeleher, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643606/ https://www.ncbi.nlm.nih.gov/pubmed/37957169 http://dx.doi.org/10.1038/s41467-023-43134-0 |
Ejemplares similares
-
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
por: Pan, Min, et al.
Publicado: (2021) -
Cell type identification in spatial transcriptomics data can be improved by leveraging cell-type-informative paired tissue images using a Bayesian probabilistic model
por: Zubair, Asif, et al.
Publicado: (2022) -
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
por: Geeleher, Paul, et al.
Publicado: (2014) -
Robust Classification of Small-Molecule Mechanism of Action Using a Minimalist High-Content Microscopy Screen and Multidimensional Phenotypic Trajectory Analysis
por: Twarog, Nathaniel R., et al.
Publicado: (2016) -
CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing
por: Connelly, Jon P., et al.
Publicado: (2019)